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Abstract
Cytokines mediate the transduction of proliferative, differentiation and survival signals in the hematopoietic system. Although
the cytokine family is large and diverse, many different cytokines display broadly overlapping functions. This can be explained
by the fact that cytokine receptors often share multiple subunits. Specificity in signal transduction can however be achieved
through several mechanisms. This review focuses on how signal specificity can be achieved within the IL-3, IL-5 and GM-CSF
receptor family. This is discussed in terms of receptor expression, recent advances in our understanding of intracellular signalling
components, and analysis of null mutant knock-out mice. © 2001 Elsevier Science Ltd. All rights reserved.
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1. Introduction
Cells of the hematopoietic system communicate util-
ising a large family of polypeptide growth factors
termed cytokines. These proteins mediate the communi-
cation of proliferative, differentiation and activation
signals to target cells. Cytokines are pleiotropic such
that a specific cytokine may act on many different cell
types, eliciting a wide range of biological responses,
depending on the target cell. Furthermore, cytokines
are also redundant, since distinct cytokines can act on a
single target cell to elicit the same response. Under-
standing the molecular structure of cytokine receptors
has provided an explanation for the functional redun-
dancy of cytokines (Fig. 1). Many cytokine receptors
consist of multiple subunits, one of which is cytokine
specific [1]. Other subunits mediate cytokine-activated
signal transduction pathways and can be shared be-
tween several cytokine receptors. Why have so many
cytokines developed if they have overlapping functions?
One could imagine that a complex system with high
redundancy has developed for the purpose of stability.
Indeed, many cytokines that have been shown to be
essential for certain specific processes in vitro, fail to
show severe phenotypical defects in null-mutant mice
(see below). This raises the question of how, in such a
complex and redundant system, specificity is achieved?
In this review we will discuss some of the mechanisms
underlying cytokine specificity in view of the IL-3:IL-5:
GM-CSF receptor family.
2. Structural organisation of the IL-3, IL-5, GM-CSF
receptor family
The receptors for IL-5, IL-3 and GM-CSF each
consist of a cytokine specific a-chain, which binds
ligand with low affinity [2,3], and a common b-chain
(bc), which is shared among all the receptors of this
family. The bc by itself does not bind ligand, but forms
a high affinity cytokine receptor only upon association
with the a-chain. In the mouse, a second b-chain has
been identified which associates exclusively with the
IL-3 a-chain (IL-3Ra), hence its name bIL-3 . Although,
this second bCIL-3 was thought to be the result of a
gene duplication after the separation between human
and mouse, recently we have identified remnants of a
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former human bIL-3 whose functionality has apparently
been lost later in evolution [4].
Many factors may contribute to specificity in sig-
nalling between the IL-3, IL-5 and GM-CSF receptors.
These receptors are differentially expressed throughout
the hematopoietic system [5]. For example, the IL-5
receptor is expressed exclusively on eosinophils,
basophils and mouse B cell precursors as well as mature
B1 cells. Stimulation with IL-5 will thus result in the
activation of a distinct subset of cells bearing the re-
spective cytokine receptor. However, many myeloid and
lymphoid progenitors may express two or more of these
receptors concomitantly.
Many receptor-initiated signals are amplified as they
are transduced. Subtle differences in signalling kinetics
at the receptor level, or receptor expression levels may
result in marked differences in the activation of down-
stream signalling components. For example, Rossi et al.
have demonstrated that the lineage commitment of a
hematopoietic precursor cell line can be controlled by
the level of PKC activity [6]. While the absence of PKC
activity maintained cells in an undifferentiated state,
low PKC activity induced differentiation of cells to-
wards a myelomonocytic phenotype. High PKC activity
however, favoured eosinophilic differentiation. More-
over, it has been reported that high concentrations of
IL-3 promote self-renewal of a murine multipotential
hematopoietic cell line, whereas low concentrations of
IL-3 in combination with GM-CSF or erythropoietin
result in differentiation towards granulocytes,
macrophages or erythroid cells [7,8]. There is also evi-
dence for specific intracellular signalling from each
individual receptor within one target cell. IL-5 has been
reported to be essential for the differentiation of early
CD34 progenitor cells into eosinophil colonies in
vitro, whereas IL-3 does not support eosinophil colony
formation, even though these early progenitors express
receptors for this cytokine [9]. These data suggest that
IL-5 signalling can, in some way, differ from signal
transduction by the IL-3 or GM-CSF receptors.
3. Is there a role for bc in mediating signal specificity?
Dimerisation is a common theme in the activation of
cell surface receptors [10] and cytokine receptors also
depend on dimerisation for their activation. Studies
using chimeric receptors consisting of the intracellular
domains of the GM-CSF a and b chains fused to the
c-jun or c-fos leucine zipper motifs have shown that
both homodimers of bc intracellular domains and het-
erodimers of GM-CSFRa and bc can induce cytokine
independent proliferation [11]. The stoichiometry of the
endogenous active receptor complex is however unclear,
although modelling studies suggest that the active re-
ceptor complex consists of two ab heterodimers [12].
Upon dimerisation, multiple tyrosine residues in the
bc become rapidly phosphorylated [2,3](Fig. 2). Two
membrane-proximal domains, including a conserved
proline rich domain, were shown to be critical for
Fig. 1. Cytokine receptor class I subfamilies. Schematic representation of the molecular structure of class I cytokine receptors. The three major
receptor families are depicted and these are subdivided according to the subunit composition of the receptors.
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Fig. 2. Potential regulators of cytokine specificity in the IL-3 receptor
family. The regulation of cytokine specific signal transduction can
occur through a variety of mechanisms which are discussed in the
text. The cell-type specific expression of a-chain subunits directly
regulates the response of a cell to a specific cytokine. Furthermore,
the intracellular domains of the different a-chains are likely candi-
dates for mediating specific signals. A variety of signal transduction
components that may interact with the a- and:or b-chains in a
cytokine or cell-type dependent manner are shown (boxed). Finally
the various bc phosphorylated tyrosine residues are depicted, each of
which may bind specific SH2-domain containing proteins.
the adaptor protein 14-3-3z [18]. This serine residue is
inducibly phosphorylated by GM-CSF in myeloid
leukemic cells and may subserve specialised functions
associated with IL-3:IL-5:GM-CSF receptors. This sug-
gests that serine phosphorylation may also play a criti-
cal role in the regulation of receptor function.
Several other tyrosine kinases have been reported to
associate with bc, including Lyn, Btk, Tec, Fyn, and
Hck [19–22]. Although their role in bc signalling is
largely unknown, the restricted expression of some of
them might provide a mechanism by which specificity in
signalling through bc is achieved. For example, expres-
sion of the tyrosine kinase Btk, is predominantly in B
cells, and this kinase might therefore mediate a specific
signal upon activation of bc in these cells. Indeed,
Koike et al. demonstrated that X-linked immunodefi-
cient mice (XID), which have a missense mutation in
the Btk gene, display impaired IL-5 signalling in B-
cells, whereas the eosinophilic development in these
mice is normal [23].
We have recently described the identification of a
novel adapter protein RACK1 that associates with the
IL-3:IL-5:GM-CSF bc [24]. RACK1 has been reported
to associate with active PKCb in a region termed the
C2 domain [25]. Indeed, PKCb was found in complex
with bc upon stimulation with either TPA or IL-5 [24].
Since there is no evidence that RACK1 associates with
other cytokine receptor subunits, the association of
RACK1 with bc might regulate signal transduction
pathways specific for the IL-3:IL-5:GM-CSF family of
receptors. Interestingly, while RACK1 is expressed in
monocytes, T and B cells and eosinophils, we observed
that RACK1 is absent from human neutrophils [24].
Thus, bc activation might lead to a cell-type specific
activation of signalling pathways downstream of
RACK1.
4. Fine-tuning specificity through cytokine receptor
a-chains
Although the bc of the IL-3:IL-5:GM-CSF receptors
initiates signal transduction events specific for this cy-
tokine family, as previously discussed it will apparently
not distinguish between IL-3, IL-5 and GM-CSF. The
cytokine specific a-chains on the other hand are likely
candidates for mediating specificity in signalling be-
tween cytokines of one family. Compared to the bc, the
IL-3Ra, IL-5Ra and GM-CSFRa intracellular domains
are rather short (around 50 amino acids). There is
however, some experimental evidence that the intracel-
lular domain of these receptors contributes to receptor
signal transduction. Indeed IL-3Ra, IL-5Ra and GM-
CSFRa have been shown to play a critical role in
receptor signal transduction, since deletion of the cyto-
plasmic domains of the a-chains does not affect high
ligand-induced phosphorylation events [13]. This ty-
rosine phosporylation is thought to be mediated by
members of the Janus kinase (JAK) family. Indeed,
Jak2 has been shown to be constitutively associated
with bc in a conserved region designated the Box 1
domain [14]. Receptor dimerisation will thus bring two
Jak2 molecules into close proximity, which enables
cross-phosphorylation and activation of the Jak2
proteins themselves, as well as phosphorylation of the
dimerised receptor subunits. There are four members of
the JAK kinase family; Jak1, Jak2, Jak3 and Tyk2 and
they demonstrate some specificity in substrate phospho-
rylation [15]. Differential expression of JAK kinases
could lead to cell type specific association of different
members of the JAK family with bc, regulating the
activation of specific downstream targets (see Fig. 2).
Phosphorylated tyrosine residues are target binding
sites for proteins containing Src-homology 2 (SH2)
domains [16]. There is a distinct binding specificity for
SH2 domains to phosphotyrosine residues allowing spe-
cificity in the association of proteins with bc versus
other cytokine receptor subunits. There are eight ty-
rosine residues present in the human bc, six of which
are conserved between the human and mouse bc (see
Fig. 2). Over the last few years much effort has been
put into the identification of signalling pathways regu-
lated by these (phosphorylated) tyrosine residues. For
example, we have recently demonstrated that the acti-
vation of the PI-3K-PKB and the Ras-ERK pathway
by IL-3:GM-CSF:IL-5 critically depends on the in-
tegrity of tyrosines Y577 and Y612 of bc [17]. Lopez
and co-workers have recently demonstrated that bc
also contains a phopshoserine motif that interacts with
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affinity ligand binding, but abrogates receptor sig-
nalling [26–31]. Deletion of the intracellular domain of
IL-5Ra has been shown to abrogate the IL-5-mediated
growth of a transfected BaF3 cell line [26]. Further-
more, ligand induced activation of JAK kinases and
tyrosine phosphorylation of intracellular proteins as
well as the activation of STAT5 was impaired by
deletion of the intracellular domain [26,27]. The intra-
cellular domains of IL-3Ra, IL-5Ra and GM-CSFRa
contain a highly conserved membrane-proximal pro-
line-rich region that has been referred to as the Box1
region [32]. A region downstream of this proline rich
domain which is less conserved between the IL-5Ra,
IL-3Ra and GM-CSFRa, has also been shown to be
critical for IL-5R mediated signalling [30]. In a recent
report, Jak2 was also shown to interact with the IL-
5Ra Box1 region, and the ability of mutants of IL-5Ra
to support IL-5R signalling correlated with the ability
to associate with Jak2 [33]. Although, the association
with the JAK kinases was uniquely demonstrated for
the IL-5Ra, the Box1 regions of IL-3Ra and GM-
CSFRa have also been shown to fulfil a similar critical
function in the support of proliferation of cytokine
dependent cell lines [28,29,31,34,35]. A role for the
a-chain in the induction of PKC activation has been
described for the GM-CSF and IL-3 receptors [29,36].
Furthermore, a single report demonstrates a direct role
for GM-CSFRa in the regulation of hexose uptake in a
tyrosine phosphorylation independent manner. This
suggests a direct signalling role for the a-chain al-
though the mechanisms underlying this observation
remain unresolved [37].
In another study, IL-5 induced proliferation of TF-1
cells could be inhibited using a phosphatase inhibitor,
whereas GM-CSF or IL-3 induced proliferation was
unaffected [36]. Conversely, the GM-CSF or IL-3 in-
duced proliferation could be inhibited utilising tyrosine
kinase inhibitors, whereas these inhibitors enhanced
IL-5 induced proliferation. Differences in tyrosine
phosphorylation patterns induced by IL-3 or GM-CSF
have also been reported by Evans et al., utilising a
multipotential hematopoietic precursor cell line
(FDCP-mix cells), stably transfected with either the
human IL-3Rabc or human GM-CSFRabc [38].
Furthermore, although both IL-3 and GM-CSF sup-
ported rescue form apoptosis of these cell lines, only
IL-3 stimulation resulted in proliferation [38]. Analysis
of the cellular morphology of cells cultured in the
presence of either IL-3 or GM-CSF revealed that cells
cultured on IL-3 had maintained their blast cell mor-
phology, whereas cells cultured on GM-CSF had differ-
entiated towards a mature phenotype [38]. Although
differences in signal transduction through the receptors
for IL-3, IL-5, GM-CSF thus clearly exist, the nature of
these differences remains as yet undefined.
5. Transgenes and knock-outs of the IL-3, IL-5,
GM-CSF receptor system
In the past few years murine knockout studies of
virtually all components of the IL-3, IL-5, GM-CSF
receptor system have been described. These have helped
to understand the specific contributions of each of the
receptor subunits in hematopoiesis. Null mutation of
the common bc rendered bone marrow cells derived
from these mice unresponsive to both IL-5 and GM-
CSF [39,40]. However, responses to IL-3 were normal,
demonstrating that in mouse, bc and bIL-3 are redun-
dant in terms of IL-3 signal transduction. bc(-:-) mice
show a reduction in eosinophil numbers in both periph-
eral blood and bone marrow [39,40]. The reduced num-
bers of eosinophils observed in bc(-:-) mice are likely to
be the result of defective IL-5 signalling, since this
phenotype was also observed in IL-5(-:-) and IL-5Ra(-:
-) mice [41,42]. Interestingly, although eosinophil num-
bers in these animals are low, these cells are not absent,
suggesting a role in the expansion of these cells whereas
bc signalling is probably redundant in mediating
eosinophil differentiation. In addition, mice have been
generated in which the gene for bIL-3 was deleted [39],
as well as double knock-out mice, lacking both bc and
bIL-3 [43]. Mice lacking bIL-3 develop normally, and
bone marrow cells derived from these mice responded
normally to both IL-5, GM-CSF as well as IL-3, again
indicating that bc and bIL-3 are redundant. Mice lack-
ing both bc and mouse bIL-3, show no additional
defects compared to the bc mutant mice [43].
Since bc null mutants provide little information
about the specific contributions of each cytokine to
hematopoiesis, the IL-5 and GM-CSF signals have
been specifically disrupted by deletion of either the gene
for the receptor a-chain or the gene encoding the
cytokine itself. GM-CSF(-:-) mice show a normal
steady-state hematopoiesis suggesting that GM-CSF is
redundant in this process [44,45]. The only abnormali-
ties were found in the lung, showing progressive accu-
mulation of surfactant lipids and proteins in the alveoli.
Extensive lymphoid hyperplasia was observed around
the lung airways and veins similar to that observed in
bc (-:-) mice [46]. This could be due to dysregulated
macrophage activation since these mice show a selective
upregulation of macrophage number and function [47–
49]
Disruption of IL-5 signalling revealed a more specific
role for this cytokine in hematopoiesis. Both mice
deficient in IL-5 and mice deficient in IL-5Ra demon-
strated decreased numbers of eosinophils, similar to the
bc(-:-) mice [41,42]. Furthermore, helminth induced
eosinophilia was absent from IL-5(-:-) and IL-5Ra(-:-)
mice, indicating that IL-5 plays an critical role in the
expansion of the eosinphil population. Both IL-5(-:-)
and IL-5Ra(-:-) mice had markedly reduced numbers
N. Geijsen et al. : Cytokine & Growth Factor Re6iews 12 (2001) 19–25 23
of CD5 B cells (B1 cells) and thymocytes, although
thymocyte numbers returned to normal levels when the
mice were 6 weeks of age. Interestingly, this effect has
not been documented for bc(-:-) mice, where peritoneal
cell populations were [42]. It is, however, unclear
whether this difference is due to a lack of experimental
data, or that it represents a true discrepancy between
bc(-:-) mice and IL-5Ra(-:-) or IL-5(-:-) mice. The
opposite effect was observed in transgenic mice, ex-
pressing high levels of IL-5 [50,51], which resulted in an
increase in peripheral white blood cells, spleen cells and
peritoneal cells. Especially an increase in eosinophils
and B-1 cells was observed. The increase in B-1 cells
was accompanied by an increase in serum IgM and IgA
levels. Analysis of null mutant mice has clearly demon-
strated that specificity in IL-3, IL-5 and GM-CSF
signalling is critical for normal hematopoietic function-
ing (Table 1).
6. Conclusions
The development of novel molecular tools such as
the yeast two-hybrid system have made the identifica-
tion of specific proteins interacting with the IL-5, IL-3
or GM-CSF receptor a-chain a possibility. Further-
more, knock-in studies using mutants of receptor a-
chains will provide additional information on the role
of specific domains of these receptor subunits in the
phenotype observed in the knock-out mice. Our current
knowledge of the temporal and spatial expression of
both the cytokines and their receptors, as well as the
possible differences in expression levels and internalisa-
tion kinetics between the IL-3, IL-5 and GM-CSF
receptors must be expanded. These might still be a
critical mechanism by which specificity in IL-3, IL-5,
GM-CSF receptor signalling is achieved through modu-
lation of signal strength. With a greater understanding
of the precise role of cytokine-specific receptor subunits
the development of novel strategies for modulating cell
function can be developed. Efficiency is realised when
signal transduction pathways are inhibited at the point
of receptor-mediated initiation preventing a signal from
becoming amplified. Several methods have been devel-
oped that allow inhibition of the synthesis of specific
proteins using anti-sense oligonucleotides or abrogation
of specific protein-protein interactions using peptides
mimicking the protein binding site. The inhibition of
cytokine receptor a-chain mediated signal transduction
pathways utilising for example peptides, derived from
the a-chain intracellular domains might provide a novel
way to specifically inhibit hematopoietic cell function.
Specifically, the ability to inhibit cytokine-mediated
proliferation and survival of subsets of hematopoietic
cells can have important therapeutic implications for
modulating a variety diseases.
Table 1
Phenotypes associated with gene disruptions of specific components of the IL-3:IL-5:GM-CSF receptor systema
bIL-3 (-:-)bc (-:-) bc (-:-)bIL-3GM-CSF (-:-)IL-5Ra (-:-)IL-5 (-:-)
(-:-)
ªªApparently normal steady state ª ª ª ª
hematopoiesis
ª ªLow eosinophil counts ª ª
ªª ª ªNo eosinophil induction upon infection or
allergen challenge
x ªReduced mucosal IgA levels
ªNormal serum IgA and total IgG levels
Normal IgM, IgA and IgG responses upon ª
antigen challenge or infection
ªReduced serum IgM and IgG3 levels
ª ªDecreased CD5 B cell levels
Decreased thymocyte levels ª
ªPulmonary proteinosis ª ª
ªImpaired adhesion and reduced ª ª
phagocytosis by alveolar macrophages
Peritoneal macrophages normal ª
No colony formation from bone marrow ªª
cells in response to IL-5 or GM-CSF
IL-3 response normal ª ªª
Increased numbers of neutrophils in BAL ª
fluid
Lymphoid hyperplasia around aiways and ª
pulmonary veins
a Ticked boxes indicate the appearance of the indicated phenotype. A cross indicates the absence of the indicated phenotype. Open boxes
indicate that the phenotype has not been reported, nor has the absence of this phenotype.
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